HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study

Overview of attention for article published in Breast Cancer, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 626)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,990 followers.

RT @lobbccanada: https://t.co/bG2OLsddEI I would like to see a study with those who have advanced ILC HER2+ subtype.

RT @lobbccanada: https://t.co/bG2OLsddEI I would like to see a study with those who have advanced ILC HER2+ subtype.

https://t.co/bG2OLsddEI I would like to see a study with those who have advanced ILC HER2+ subtype.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.